Northeast Regional Epilepsy Group - Morristown - 310 Madison Ave — Morristown, New Jersey

Northeast Regional Epilepsy Group - Morristown - 310 Madison Ave is a clinical research site located in Morristown, New Jersey, United States 07960.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Northeast Regional Epilepsy Group - Morristown - 310 Madison Ave has participated in 3 clinical trials with 3 currently active.

Therapeutic areas: Developmental and Epileptic Encephalopathy, Dravet Syndrome.

Sponsors: Longboard Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Northeast Regional Epilepsy Group - Morristown - 310 Madison Ave?

Northeast Regional Epilepsy Group - Morristown - 310 Madison Ave has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Northeast Regional Epilepsy Group - Morristown - 310 Madison Ave conducted?

Northeast Regional Epilepsy Group - Morristown - 310 Madison Ave has 3 clinical trials on record, with 3 currently active. Their work covers Developmental and Epileptic Encephalopathy, Dravet Syndrome.

Is Northeast Regional Epilepsy Group - Morristown - 310 Madison Ave accredited by Crixeo Health?

Northeast Regional Epilepsy Group - Morristown - 310 Madison Ave has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Northeast Regional Epilepsy Group - Morristown - 310 Madison Ave?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.